Two products better than one

DNA sequencing company Pyrosequencing AB and chemistry company Personal Chemistry AB believe they can save $9 million a year in expenses by combining, and perhaps reach break even next year. But with two unrelated product lines that are sold into two different markets, the leverage for creating a diversified global supply company is less clear.

The deal is the first done by Jeff Bork, who recently became chairman of Pyrosequencing (SSE:PYRO A, Uppsala, Sweden).

"I stepped in as chairman of Pyro in April and showed the board a plan for potential acquisitions," he said. "At

Read the full 944 word article

How to gain access

Continue reading with a
two-week free trial.